TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
SBM Life Science AB
Closing information (x1000 EUR)
Closing information | 2023/09 | 2022/09 | 2021/09 |
Turnover |
15,658
|
19,626
|
19,899 |
Financial expenses |
528
|
486
|
287 |
Earnings before taxes |
-118
|
386
|
511 |
EBITDA |
334
|
823
|
759 |
Total assets |
9,118
|
15,275
|
8,451 |
Current assets |
9,025
|
15,186
|
8,258 |
Current liabilities |
7,672
|
13,637
|
7,025 |
Equity capital |
1,447
|
1,638
|
1,427 |
- share capital |
4
|
5
![]() |
5 |
Employees (average) |
18
|
19
|
27 |
Financial ratios
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Solvency |
15.9%
|
10.7%
|
16.9% |
Turnover per employee |
870
|
1,033
|
737 |
Profit as a percentage of turnover |
-0.8%
|
2.0%
|
2.6% |
Return on assets (ROA) |
4.5%
|
5.7%
|
9.4% |
Current ratio |
117.6%
|
111.4%
|
117.6% |
Return on equity (ROE) |
-8.2%
|
23.6%
|
35.8% |
Change turnover |
-2,987
|
1,034
|
892 |
Change turnover % |
-16%
|
6%
|
5% |
Chg. No. of employees |
-1
|
-8
|
-3 |
Chg. No. of employees % |
-5%
|
-30%
|
-10% |
Total value of public sale
Fiscal year | 2023/09 | 2022/09 | 2021/09 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.